Skip to main content
. 2016 Mar 1;8(1):86–91. doi: 10.4274/jcrpe.2512

Figure 1. Height, bone age, and body mass index data. Levothyroxine treatment was initiated at age 9 years and 3 months. At age 10 years and 4 months, growth hormone replacement therapy was started.

Figure 1